Founded in 2024, Synthio Labs is building the operating system for modern life sciences teams: a clinical-grade conversational AI platform designed to support every clinician and patient at scale.

Pharma companies spend over $30B every year trying to engage their customers, yet outreach remains manual, fragmented, and slow, contributing to treatment drop-off rates that can reach 50% in long-term conditions. The industry doesn’t just need more engagement - it needs better, faster, and more secure and compliant engagement.

Synthio’s AI OS brings together voice, data, and intelligence across three core products:

• Jarvis - a voice AI copilot built for field teams.
• Ather - a multimodal engine powering omnichannel physician and patient conversations.
• Simulation Studio - digital twins of clinicians that help teams test strategies and plan with precision.

All three products are built on HIPAA-compliant, SOC2-ready infrastructure, with real-time reasoning, millisecond-level data access, and strict content-guardrails to ensure 100% traceability.

Their early adopters include top 10 pharma and leading D2C healthcare companies who are reimagining how they support clinicians and patients.

Synthio Labs is defining the next generation of customer engagement infrastructure for life sciences, bringing consumer-grade intelligence to an industry ready for transformation.